Aspirin inhibits tumor necrosis factor-α gene expression in murine tissue macrophages

Molecular Pharmacology

Volumn 52, Issue 3, 1997, Pages 421-429

  Shackelford, Rodney E ^a   Alford, Paul B ^a   Xue, Yan ^a   Thai, Sheau Fung ^a   Adams, Dolph O ^a   Pizzo, Salvatore ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; GENE EXPRESSION; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION;

EID: 0030851109     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.52.3.421     Document Type: Article

References (37)

1. Adams, D. O., and T. A. Hamilton. Macrophages as destructive cells in host defense, in Inflammation: Basic Principles and Clinical Correlates (J. I. Gallin, I. M. Goldstein, and R. Snyderman, eds.). Raven Press, New York, 471-492 (1988).
2. Gilman, A. G., T. W. Rall, A. S. Nies, and P. Taylor, eds. The Pharmacological Basis of Therapeutics, Pergamon Press, New York, 638-681 (1990).
3. Abramson, S., H. Korchak, R. Ludewig, H. Edelson, K. Haines, R. I. Levin, R. Herman, R. Rider, S. Kimmel, and G. Weissmann. Modes of action of aspirin-like drugs Proc. Acad. Sci. USA Vol. 86:7227-7231 (1985).
4. Kopp, E., and G. Sankar. Inhibition of NF-κB binding by sodium salicylate and aspirin. Science (Washington D. C.) 265:956-959 (1994).
5. Baeuerle, P. A., and T. Henkel. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141-179 (1994).
6. Collart, M. A., P. Baeuerle, and P. Vassalli. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four κB-like motifs and of constitutive and inducible forms of NF-κB. Mol. Cell. Biol. 10:1498-1506 (1990).
7. Shakhov, A. N., M. A. Collart, P. Vassalli, S. A. Nedospasov, and C. V. Jongeneel. κB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor-α gene in primary macrophages. J. Exp. Med. 174:35-47 (1990).
8. Drouet, C., A. N. Shakhov, and C. V. Jongeneel. Enhancers and transcription factors controlling the inducibility of the tumor necrosis factor-α promoter in primary macrophages. J. Immunol. 147:1694-1700 (1991).
9. Hamilton, T. A., J. E. Weiel, and D. O Adams. Expression of the transferrin receptor in murine peritoneal macrophages is modulated in the different stages of activation. J. Immunol. 132:2285-2290 (1984).
10. Shackelford, R. E., U. K. Misra, K. Florine-Castell, S.-F Thai, S. V. Pizzo, and D. O. Adams. Oxidized low density lipoprotein suppresses activation of NF-κB in macrophages via a pertussis toxin-sensitive signaling mechanism. J. Biol. Chem. 270:3475-3478 (1995).
11. Dignam, J. D., M. R. Lebovitz, and R. D. Roeder. Accurate transcription initiated by RNA polymerase II in a soluable extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-4489 (1983).
12. Bradford, M. M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254 (1976).
13. Introna, M., R. C. Bast, Jr., C. S. Tannenbaum, T. A. Hamilton, and D. O. Adams. The effects of LPS on the early 'competence' genes JE and KC in murine peritoneal macrophages. J. Immunol. 138:3891-3896 (1987).
14. Sheau-Fung, Yu, T. J. Koerner, and D. O. Adams. Gene regulation in macrophage activation: differential regulation of genes encoding for tumor necrosis factor, interleukin-1, JE, and KC by interferon-γ and lipopolysaccharide. J. Leukocyte Biol. 48:412-419 (1990).
15. Figueiredo, F., T. J. Koerner, and D. O. Adams. Molecular mechanisms regulating the expression of class II histocompatibility molecules on macrophages. J. Immunol. 143:3781-3786 (1989).
16. Koerner, T. J., T. A. Hamilton, M. Introna, C. S. Tannenbaum, R. C. Bast, Jr., and D. O. Adams. The early competence genes JE and KC are differentially regulated in murine peritoneal macrophages in response to lipopolysaccharide. Biochem. Biophys. Res. Commun. 149:969-974 (1987).
17. Greenberg, M. E., and E. B. Ziff. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature (Lond.) 311:433-438 (1984).
18. Denizot, F., and R. Lang. Rapid colormetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 89:271-277 (1986).
19. Tachibana, K., G. J. Chen, D. S. Huang, P. Scuderi, and R. R. Watson. Production of tumor necrosis factor alpha by resident and activated murine macrophages. J. Leukocyte Biol. 51:251-255 (1992).
20. Abramson, S. B., J. Leszczynska-Piziak, R. M. Clancy, M. Philips, and G. Weissmann. Inhibition of neutrophil function by aspirin-like drugs (NSAIDS): requirement for assembly of heterotrimeric G proteins in bilayer phospholipid. Biochem. Pharmacol. 47:563-572 (1994).
21. Pierce, J. W., M. A. Read, H. D. Ding, F. W. Luscinskas, and T. Collins. Salicylayes inhibit IκB-α phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration. J. Immunol. 156: 3961-1969 (1996).
22. Oeth, P., and N. Mackman. Salicylates inhibit lipopolysaccharide-induced transcriptional activation of the tissue factor gene in human monocytic cells. Blood 86:4144-4152 (1995).
23. Amin, A. R., P. Vyas, M. Attur, J. Leszczynska-Piziak, I. R. Patel, G. Weissmann, and S. B. Abramson. The mode of action of aspirin-like drugs: effect on inducible nitric oxide synthase. Proc. Natl. Acad. Sci. USA 92: 7926-7430 (1995).
24. Palmoski, M. J., and K. D. Brandt. Effects of salicylate and indomethacin on glycosaminoglycan and prostaglandin E2 synthesis in intact canine knee cartilage ex vivo. Arthritis Rheum. 27:398-403 (1984).
25. Palmoski, M. J., and K. D. Brandt. Correction of data on salicylate and indomethacin concentrations in cartilage. Arthritis Rheum. 28:23 (1985).
26. Lowenstein, C. J., E. W. Alley, P. Ravel, A. M. Snowman, S. H. Snyder, S. W. Russell, and W. J. Murphy. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon γ and lipopolysaccharide. Proc. Natl. Acad. Sci. USA 90:9730-9734 (1993).
27. Xie, Q.-W., R. Whisnant, and C. Nathan. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J. Exp. Med. 177: 1779-1784 (1993).
28. Xie, Q.-W., Y. Kashiwabara, and C. Nathan. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269:4705-4708 (1994).
29. Aeberhard, E. E., S. A. Henderson, N. S. Arabolos, J. M. Griscavage, F. E. Castro, C. T. Barret, and L. Ignarro. Nonsteroidal anti-inflammatory drugs inhibit expression of the inducible nitric oxide synthase gene. Biochem. Biophys. Res. Commun. 208:1053-1059 (1995).
30. Rink, L., and Kirchner, H. Recent progress in the tumor necrosis factor-alpha field. Int. Arch. Allergy Immunol. 111:199-209 (1996).
31. Feldmann, M. What is the mechanism of action of anti-tumor necrosis factor-alpha antibody in rheumatoid arthritis? Int. Arch. Allergy Immunol. 111:362-365 (1996).
32. Hunt, J. S., Chen, H. L., and Miller, L. Tumor necrosis factors: pivotal components of pregnancy? Biol. Reprod. 54:554-562 (1996).
33. Szabo, C. Alterations in nitric oxide production in various forms of circulatory shock. New Horizons 3:2-3 (1995).
34. Halushka, P. V., W. C. Wise, and J. A. Cook. Studies on the beneficial effects of aspirin in endotoxic shock. Am. J. Med. 74:91-96 (1983).
35. Macnaul, K. L., N. L. Hutchinson, J. N. Parsons, E. K. Bayne, and M. J. Tocci. Analysis of IL-1 and TNF-α gene expression in human rheumatoid synoviocytes and normal monocytes by in situ hybridization. J. Immunol. 145:4154-4166 (1990).
36. Brennan, F. M., R. N. Maini, and M. Feldman. Cytokine expression in chronic inflammatory disease. Br. Med. Bull 51:368-384 (1995).
37. Maini, R. N., M. J. Elliot, F. M. Brennan, and M. Feldman. Beneficial effects of tumor necrosis factor-alpha blockade in rheumatoid arthritis. Clin. Exp. Immunol. 101:207-212 (1995).